Literature DB >> 22357276

Molecular characterization of the processing of arenavirus envelope glycoprotein precursors by subtilisin kexin isozyme-1/site-1 protease.

Dominique J Burri1, Giulia Pasqual, Cylia Rochat, Nabil G Seidah, Antonella Pasquato, Stefan Kunz.   

Abstract

A crucial step in the life cycle of arenaviruses is the biosynthesis of the mature fusion-active viral envelope glycoprotein (GP) that is essential for virus-host cell attachment and entry. The maturation of the arenavirus GP precursor (GPC) critically depends on proteolytic processing by the cellular proprotein convertase (PC) subtilisin kexin isozyme-1 (SKI-1)/site-1 protease (S1P). Here we undertook a molecular characterization of the SKI-1/S1P processing of the GPCs of the prototypic arenavirus lymphocytic choriomeningitis virus (LCMV) and the pathogenic Lassa virus (LASV). Previous studies showed that the GPC of LASV undergoes processing in the endoplasmic reticulum (ER)/cis-Golgi compartment, whereas the LCMV GPC is cleaved in a late Golgi compartment. Herein we confirm these findings and provide evidence that the SKI-1/S1P recognition site RRLL, present in the SKI-1/S1P prodomain and LASV GPC, but not in the LCMV GPC, is crucial for the processing of the LASV GPC in the ER/cis-Golgi compartment. Our structure-function analysis revealed that the cleavage of arenavirus GPCs, but not cellular substrates, critically depends on the autoprocessing of SKI-1/S1P, suggesting differences in the processing of cellular and viral substrates. Deletion mutagenesis showed that the transmembrane and intracellular domains of SKI-1/S1P are dispensable for arenavirus GPC processing. The expression of a soluble form of the protease in SKI-I/S1P-deficient cells resulted in the efficient processing of arenavirus GPCs and rescued productive virus infection. However, exogenous soluble SKI-1/S1P was unable to process LCMV and LASV GPCs displayed at the surface of SKI-I/S1P-deficient cells, indicating that GPC processing occurs in an intracellular compartment. In sum, our study reveals important differences in the SKI-1/S1P processing of viral and cellular substrates.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22357276      PMCID: PMC3347368          DOI: 10.1128/JVI.00024-12

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  45 in total

Review 1.  Lymphocytic choriomeningitis virus: a prenatal and postnatal threat.

Authors:  Daniel J Bonthius
Journal:  Adv Pediatr       Date:  2009

2.  A key enzyme in the biogenesis of lysosomes is a protease that regulates cholesterol metabolism.

Authors:  Katrin Marschner; Katrin Kollmann; Michaela Schweizer; Thomas Braulke; Sandra Pohl
Journal:  Science       Date:  2011-07-01       Impact factor: 47.728

3.  Role of the host cell's unfolded protein response in arenavirus infection.

Authors:  Giulia Pasqual; Dominique J Burri; Antonella Pasquato; Juan Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2010-11-24       Impact factor: 5.103

4.  Antiviral activity of a small-molecule inhibitor of arenavirus glycoprotein processing by the cellular site 1 protease.

Authors:  Shuzo Urata; Nadezhda Yun; Antonella Pasquato; Slobodan Paessler; Stefan Kunz; Juan Carlos de la Torre
Journal:  J Virol       Date:  2010-11-10       Impact factor: 5.103

5.  Targeting the proteolytic processing of the viral glycoprotein precursor is a promising novel antiviral strategy against arenaviruses.

Authors:  Jillian M Rojek; Giulia Pasqual; Ana B Sanchez; Ngoc-Thao Nguyen; Juan-Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

6.  Molecular and cell biology of the prototypic arenavirus LCMV: implications for understanding and combating hemorrhagic fever arenaviruses.

Authors:  Juan C de la Torre
Journal:  Ann N Y Acad Sci       Date:  2009-09       Impact factor: 5.691

7.  Different mechanisms of cell entry by human-pathogenic Old World and New World arenaviruses.

Authors:  Jillian M Rojek; Ana B Sanchez; Ngoc Thao Nguyen; Juan-Carlos de la Torre; Stefan Kunz
Journal:  J Virol       Date:  2008-05-28       Impact factor: 5.103

8.  The proprotein convertase SKI-1/S1P: alternate translation and subcellular localization.

Authors:  Philomena Pullikotil; Suzanne Benjannet; Janice Mayne; Nabil G Seidah
Journal:  J Biol Chem       Date:  2007-07-10       Impact factor: 5.157

9.  A new arenavirus in a cluster of fatal transplant-associated diseases.

Authors:  Gustavo Palacios; Julian Druce; Lei Du; Thomas Tran; Chris Birch; Thomas Briese; Sean Conlan; Phenix-Lan Quan; Jeffrey Hui; John Marshall; Jan Fredrik Simons; Michael Egholm; Christopher D Paddock; Wun-Ju Shieh; Cynthia S Goldsmith; Sherif R Zaki; Mike Catton; W Ian Lipkin
Journal:  N Engl J Med       Date:  2008-02-06       Impact factor: 91.245

10.  Inhibition of Lassa virus glycoprotein cleavage and multicycle replication by site 1 protease-adapted alpha(1)-antitrypsin variants.

Authors:  Anna Maisa; Ute Ströher; Hans-Dieter Klenk; Wolfgang Garten; Thomas Strecker
Journal:  PLoS Negl Trop Dis       Date:  2009-06-02
View more
  21 in total

1.  Biological Characterization of Conserved Residues within the Cytoplasmic Tail of the Pichinde Arenaviral Glycoprotein Subunit 2 (GP2).

Authors:  Hinh Ly; Yuying Liang; Junjie Shao; Qinfeng Huang; Xiaoying Liu; Da Di; Mythili Dileepan; Morgan Brisse
Journal:  J Virol       Date:  2019-10-29       Impact factor: 5.103

2.  A Molecular Sensor To Characterize Arenavirus Envelope Glycoprotein Cleavage by Subtilisin Kexin Isozyme 1/Site 1 Protease.

Authors:  Joel Oppliger; Joel Ramos da Palma; Dominique J Burri; Eric Bergeron; Abdel-Majid Khatib; Christina F Spiropoulou; Antonella Pasquato; Stefan Kunz
Journal:  J Virol       Date:  2015-10-28       Impact factor: 5.103

3.  Zymogen activation and subcellular activity of subtilisin kexin isozyme 1/site 1 protease.

Authors:  Joel Ramos da Palma; Dominique Julien Burri; Joël Oppliger; Marco Salamina; Laura Cendron; Patrizia Polverino de Laureto; Nabil Georges Seidah; Stefan Kunz; Antonella Pasquato
Journal:  J Biol Chem       Date:  2014-11-05       Impact factor: 5.157

Review 4.  Structure-function relationship of the mammarenavirus envelope glycoprotein.

Authors:  Wei Wang; Zheng Zhou; Leike Zhang; Shaobo Wang; Gengfu Xiao
Journal:  Virol Sin       Date:  2016-08-04       Impact factor: 4.327

5.  Adenoviral vector-based vaccine is fully protective against lethal Lassa fever challenge in Hartley guinea pigs.

Authors:  Junki Maruyama; Elizabeth J Mateer; John T Manning; Rachel Sattler; Alexey V Seregin; Natalya Bukreyeva; Frank R Jones; Joseph P Balint; Elizabeth S Gabitzsch; Cheng Huang; Slobodan Paessler
Journal:  Vaccine       Date:  2019-09-24       Impact factor: 3.641

6.  The role of proteolytic processing and the stable signal peptide in expression of the Old World arenavirus envelope glycoprotein ectodomain.

Authors:  Dominique J Burri; Antonella Pasquato; Joel Ramos da Palma; Sebastien Igonet; Michael B A Oldstone; Stefan Kunz
Journal:  Virology       Date:  2012-12-04       Impact factor: 3.616

7.  Mechanism of Folding and Activation of Subtilisin Kexin Isozyme-1 (SKI-1)/Site-1 Protease (S1P).

Authors:  Joel Ramos da Palma; Laura Cendron; Nabil Georges Seidah; Antonella Pasquato; Stefan Kunz
Journal:  J Biol Chem       Date:  2015-12-08       Impact factor: 5.157

Review 8.  Targeting virulence mechanisms for the prevention and therapy of arenaviral hemorrhagic fever.

Authors:  Lisa McLay; Aftab Ansari; Yuying Liang; Hinh Ly
Journal:  Antiviral Res       Date:  2012-12-20       Impact factor: 5.970

9.  Mutational Analysis of Lassa Virus Glycoprotein Highlights Regions Required for Alpha-Dystroglycan Utilization.

Authors:  Marissa Acciani; Jacob T Alston; Guohui Zhao; Hayley Reynolds; Afroze M Ali; Brian Xu; Melinda A Brindley
Journal:  J Virol       Date:  2017-08-24       Impact factor: 5.103

10.  Structural and functional analysis of the CspB protease required for Clostridium spore germination.

Authors:  Chloe M Adams; Brian E Eckenroth; Emily E Putnam; Sylvie Doublié; Aimee Shen
Journal:  PLoS Pathog       Date:  2013-02-07       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.